Anti-tumor necrosis factor therapy for sepsis: Still a player?

被引：0
|
作者：
Dellinger, RP [1 ]
机构：
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
来源：
CRITICAL CARE MEDICINE | 2001年 / 29卷 / 04期
关键词：
sepsis; severe sepsis; anti-tumor necrosis factor therapy; recombinant activated protein C; corticosteroids;
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：905 / 906
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab1)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
    Panacek, EA
    Marshall, JC
    Albertson, TE
    Johnson, DH
    Johnson, S
    MacArthur, RD
    Miller, M
    Barchuk, WT
    Fischkoff, S
    Kaul, M
    Teoh, L
    Van Meter, L
    Daum, L
    Lemeshow, S
    Hicklin, G
    Doig, C
    CRITICAL CARE MEDICINE, 2004, 32 (11) : 2173 - 2182
  • [42] TUMOR-NECROSIS-FACTOR-ALPHA - ITS ROLE IN THE METABOLIC RESPONSE TO SEPSIS
    VANDERPOLL, T
    SAUERWEIN, HP
    CLINICAL SCIENCE, 1993, 84 (03) : 247 - 256
  • [43] Tumor necrosis factor binding protein improves incisional wound healing in sepsis
    Maish, G
    Shumate, ML
    Ehrlich, HP
    Cooney, RN
    JOURNAL OF SURGICAL RESEARCH, 1998, 78 (02) : 108 - 117
  • [44] A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
    Stuber, F
    Petersen, M
    Bokelmann, F
    Schade, U
    CRITICAL CARE MEDICINE, 1996, 24 (03) : 381 - 384
  • [45] Tumor necrosis factor mediates impaired wound healing in chronic abdominal sepsis
    Cooney, R
    Iocono, J
    Maish, G
    Smith, JS
    Ehrlich, P
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1997, 42 (03) : 415 - 420
  • [46] Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor α antibody (infliximab) in Crohn's disease
    Detková, Z
    Kupcova, V
    Príkazská, M
    Turecky, L
    Weissová, S
    Jahnová, E
    PHYSIOLOGICAL RESEARCH, 2003, 52 (01) : 95 - 100
  • [47] Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-l receptor and Fas/FasL, in sepsis
    De Freitas, I
    Fernández-Somoza, M
    Essenfeld-Sekler, E
    Cardier, JE
    CHEST, 2004, 125 (06) : 2238 - 2246
  • [48] AMITRIPTYLINE TREATMENT MITIGATES SEPSIS-INDUCED TUMOR NECROSIS FACTOR EXPRESSION AND COAGULOPATHY
    Xia, Brent T.
    Beckmann, Nadine
    Winer, Leah K.
    Kim, Young
    Goetzman, Holly S.
    Veile, Rosalie E.
    Gulbins, Erich
    Goodman, Michael D.
    Nomellini, Vanessa
    Caldwell, Charles C.
    SHOCK, 2019, 51 (03): : 356 - 363
  • [49] Anti-tumor necrosis factor VNAR single domains reduce lethality and regulate underlying inflammatory response in a murine model of endotoxic shock
    Bojalil, Rafael
    Teresa Mata-Gonzalez, Maria
    Sanchez-Munoz, Fausto
    Yee, Yepci
    Argueta, Ivan
    Bolanos, Lucia
    Manuel Amezcua-Guerra, Luis
    Amanda Camacho-Villegas, Tanya
    Sanchez-Castrejon, Edna
    Jakob Garcia-Ubbelohde, Walter
    Fedorovish Licea-Navarro, Alexei
    Marquez-Velasco, Ricardo
    Fernando Paniagua-Solis, Jorge
    BMC IMMUNOLOGY, 2013, 14
  • [50] The tumor necrosis factor polymorphism TNF (-308) is associated with susceptibility to meningococcal sepsis, but not with lethality
    Read, Robert C.
    Teare, Dawn M.
    Pridmore, Alison C.
    Naylor, Simone C.
    Timms, James M.
    Kaczmarski, Edward B.
    Borrow, Raymond
    Wilson, Anthony G.
    CRITICAL CARE MEDICINE, 2009, 37 (04) : 1237 - 1243
12345